1.
JAMA Oncol
; 9(6): 864-866, 2023 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37052904
RESUMO
This nonrandomized controlled trial used a 1-to-1 therapist-to-patient ratio to administer psilocybin to groups of patients with cancer who were diagnosed with major depression disorder to create a scalable, rapidly effective depression treatment.